Literature DB >> 16990795

Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.

Katie Schumm1, Sonia Rocha, Jorge Caamano, Neil D Perkins.   

Abstract

The p52/p100 nuclear factor kappa B (NF-kappaB) subunit (NF-kappaB2) is aberrantly expressed in many tumour types and has been implicated as a regulator of cell proliferation. Here, we demonstrate that endogenous p52 is a direct regulator of Cyclin D1 expression. However, stimulation of Cyclin D1 expression alone cannot account for all the cell cycle effects of p52/p100 and we also find that p52 represses expression of the Cyclin-dependent kinase inhibitor p21(WAF/CIP1). Significantly, this latter effect is dependent upon basal levels of the tumour suppressor p53. By contrast, p52 cooperates with p53 to regulate other known p53 target genes such as PUMA, DR5, Gadd45alpha and Chk1. p52 associates directly with these p53-regulated promoters where it regulates coactivator and corepressor binding. Moreover, recruitment of p52 is p53 dependent and does not require p52-DNA-binding activity. These results reveal a complex role for p52 as regulator of cell proliferation and p53 transcriptional activity. Furthermore, they imply that in some cell types, p52 can regulate p53 function and influence p53-regulated decision-making following DNA damage and oncogene activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990795      PMCID: PMC1618099          DOI: 10.1038/sj.emboj.7601343

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor.

Authors:  Gaynor J Bates; Samantha M Nicol; Brian J Wilson; Anne-Marie F Jacobs; Jean-Christophe Bourdon; Julie Wardrop; David J Gregory; David P Lane; Neil D Perkins; Frances V Fuller-Pace
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

3.  Expression of the Bcl-3 proto-oncogene suppresses p53 activation.

Authors:  David Kashatus; Patricia Cogswell; Albert S Baldwin
Journal:  Genes Dev       Date:  2005-12-29       Impact factor: 11.361

4.  Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.

Authors:  Shashirekha Shetty; Bonnie A Graham; Jennifer G Brown; Xiaojie Hu; Nicolette Vegh-Yarema; Gary Harding; James T Paul; Spencer B Gibson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 5.  Good cop, bad cop: the different faces of NF-kappaB.

Authors:  N D Perkins; T D Gilmore
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

6.  p53 is a suppressor of inflammatory response in mice.

Authors:  Elena A Komarova; Vadim Krivokrysenko; Kaihua Wang; Nickolay Neznanov; Mikhail V Chernov; Pavel G Komarov; Marie-Luise Brennan; Tatiana V Golovkina; Oskar W Rokhlin; Dmitry V Kuprash; Sergei A Nedospasov; Stanley L Hazen; Elena Feinstein; Andrei V Gudkov
Journal:  FASEB J       Date:  2005-04-05       Impact factor: 5.191

7.  Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation.

Authors:  Kyu-Jin Park; Venkatesh Krishnan; Bert W O'Malley; Yumi Yamamoto; Richard B Gaynor
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

8.  Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues.

Authors:  James C Lo; Soumen Basak; Ethan S James; Raechel S Quiambo; Marcus C Kinsella; Maria-Luisa Alegre; Falk Weih; Guido Franzoso; Alexander Hoffmann; Yang-Xin Fu
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

9.  Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression.

Authors:  Sandrine Tyteca; Marie Vandromme; Gaëlle Legube; Martine Chevillard-Briet; Didier Trouche
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

10.  Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases.

Authors:  Ajay Kumar; Zhiyong Lin; Sucharita SenBanerjee; Mukesh K Jain
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

View more
  65 in total

1.  IKK and NF-kappaB-mediated regulation of Claspin impacts on ATR checkpoint function.

Authors:  Niall Steven Kenneth; Sharon Mudie; Sonia Rocha
Journal:  EMBO J       Date:  2010-07-23       Impact factor: 11.598

Review 2.  NF-kappaB pathways in the immune system: control of the germinal center reaction.

Authors:  Christine A Goetz; Albert S Baldwin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Nuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15.

Authors:  Sarah L Doyle; Kari Ann Shirey; Anne F McGettrick; Elaine F Kenny; Susan Carpenter; Brian E Caffrey; Siobhan Gargan; Susan R Quinn; Jorge H Caamaño; Paul Moynagh; Stefanie N Vogel; Luke A O'Neill
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

4.  Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.

Authors:  Gouri Sankar Sen; Suchismita Mohanty; Dewan Md Sakib Hossain; Sankar Bhattacharyya; Shuvomoy Banerjee; Juni Chakraborty; Shilpi Saha; Pallab Ray; Pushpak Bhattacharjee; Debaprasad Mandal; Arindam Bhattacharya; Samit Chattopadhyay; Tanya Das; Gaurisankar Sa
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

5.  Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.

Authors:  Marianna Penzo; Paul E Massa; Eleonora Olivotto; Francesca Bianchi; Rosa Maria Borzi; Adedayo Hanidu; Xiang Li; Jun Li; Kenneth B Marcu
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

6.  cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.

Authors:  Rosanna Lau; Min Ying Niu; M A Christine Pratt
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 7.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

8.  PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis.

Authors:  P Wang; W Qiu; C Dudgeon; H Liu; C Huang; G P Zambetti; J Yu; L Zhang
Journal:  Cell Death Differ       Date:  2009-05-15       Impact factor: 15.828

9.  Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.

Authors:  Nadine Martin; Klaus Schwamborn; Henning Urlaub; Boyi Gan; Jun-Lin Guan; Anne Dejean
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

10.  Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin.

Authors:  Brian K Bednarski; Albert S Baldwin; Hong Jin Kim
Journal:  PLoS One       Date:  2009-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.